Millennium Management’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,220
Closed -$18.7K 6175
2024
Q3
$18.7K Buy
+12,220
New +$18.6K ﹤0.01% 5808
2024
Q2
Sell
-139,957
Closed -$216K 6185
2024
Q1
$216K Sell
139,957
-140,975
-50% -$230K ﹤0.01% 5336
2023
Q4
$458K Buy
280,932
+148,274
+112% +$254K ﹤0.01% 4696
2023
Q3
$395K Sell
132,658
-238,453
-64% -$908K ﹤0.01% 4783
2023
Q2
$1.66M Buy
+371,111
New +$1.66M ﹤0.01% 3640
2023
Q1
Sell
-121,693
Closed -$377K 6582
2022
Q4
$377K Sell
121,693
-2,710
-2% -$6.9K ﹤0.01% 4941
2022
Q3
$328K Sell
124,403
-80,468
-39% -$181K ﹤0.01% 5292
2022
Q2
$297K Buy
204,871
+29,866
+17% +$45.4K ﹤0.01% 5379
2022
Q1
$320K Buy
175,005
+161,141
+1,162% +$502K ﹤0.01% 5480
2021
Q4
$66K Sell
13,864
-32,216
-70% -$130K ﹤0.01% 6404
2021
Q3
$119K Buy
46,080
+13,538
+42% +$35.7K ﹤0.01% 6356
2021
Q2
$97K Buy
32,542
+2,027
+7% +$6.72K ﹤0.01% 6242
2021
Q1
$119K Buy
+30,515
New +$156K ﹤0.01% 5658
2020
Q1
Sell
-120,070
Closed -$475K 4148
2019
Q4
$475K Sell
120,070
-40,451
-25% -$118K ﹤0.01% 3414
2019
Q3
$396K Sell
160,521
-717,303
-82% -$2.09M ﹤0.01% 3405
2019
Q2
$2.77M Buy
877,824
+840,456
+2,249% +$26.6M ﹤0.01% 2210
2019
Q1
$1.41M Sell
37,368
-34,785
-48% -$1.3M ﹤0.01% 2649
2018
Q4
$2.62M Buy
72,153
+11,080
+18% +$341K ﹤0.01% 2030
2018
Q3
$2.1M Buy
61,073
+1,658
+3% +$53.5K ﹤0.01% 2397
2018
Q2
$1.92M Buy
+59,415
New +$2.05M ﹤0.01% 2437
2018
Q1
Sell
-50,742
Closed -$1.06M 3841
2017
Q4
$1.06M Buy
+50,742
New +$916K ﹤0.01% 2666

Other funds holding IFRX

Millennium Management's IFRX Position: Q4 2024 in Review

Millennium Management sold out of InflaRx (IFRX) in Q4 2024, closing a stake of 12,220 shares — an estimated $18.7K sold.

Millennium Management first reported a position in IFRX in Q4 2017 and held it in 21 quarters. The position peaked at $2.77M in Q2 2019. 30 funds tracked by Wall St. Rank hold IFRX as of Q4 2024.

  • Millennium Management reported no remaining InflaRx position as of Q4 2024 after selling out during the quarter.
  • Millennium Management sold 12,220 InflaRx shares in Q4 2024, an estimated $18.7K.
  • Millennium Management first reported a position in InflaRx in Q4 2017 and held it in 21 quarters.
  • Millennium Management's InflaRx position peaked at $2.77M in Q2 2019.
  • 30 funds tracked by Wall St. Rank held InflaRx as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.